Female Libido Drug Nets FDA Approval, with Warning

Branded with the name “Addyi” and marketed as the “female Viagra”, this new pink pill drug is targeted towards premenopausal women with hypoactive sexual desire disorder (HSDD). It was twice rejected by the FDA and comes with warnings of severe hypotension and syncope; Public Citizen predicted the drug will be pulled from the market within a few years.

Full article: http://tinyurl.com/nrgt3wf

About Vivian

I am a medical student who is trying to live a healthy lifestyle by doing yoga, running, learning new things, and surrounding myself in positive images, ideas, and people.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: